Generic Drugs Continue to Skyrocket in Price while Specialty Drugs Take Center Stage
On the minds of every employer today is the cost of specialty drugs, however as industry focus shifts, generic drugs are seeing a dramatic rise in costs. Turing pharmaceuticals and the Daraprim fiasco brought to light a much larger problem. Martin Shkreli leveraged the ongoing trend of purchasing off-patent drugs...
Read more